These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17220558)
1. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients. Chrzanowska M; Kurzawski M; Droździk M; Mazik M; Oko A; Czekalski S Pharmacol Rep; 2006; 58(6):973-8. PubMed ID: 17220558 [TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia. Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254 [TBL] [Abstract][Full Text] [Related]
3. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099 [TBL] [Abstract][Full Text] [Related]
4. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia. Lennard L; Cartwright CS; Wade R; Richards SM; Vora A Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716 [TBL] [Abstract][Full Text] [Related]
5. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401 [TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Yates CR; Krynetski EY; Loennechen T; Fessing MY; Tai HL; Pui CH; Relling MV; Evans WE Ann Intern Med; 1997 Apr; 126(8):608-14. PubMed ID: 9103127 [TBL] [Abstract][Full Text] [Related]
7. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes. Nishida A; Kubota T; Yamada Y; Higashi K; Kitamura K; Nakahara K; Iga T Clin Chim Acta; 2002 Sep; 323(1-2):147-50. PubMed ID: 12135816 [TBL] [Abstract][Full Text] [Related]
8. Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China). Zhang LR; Song DK; Zhang W; Zhao J; Jia LJ; Xing DL Clin Chim Acta; 2007 Feb; 376(1-2):45-51. PubMed ID: 16952345 [TBL] [Abstract][Full Text] [Related]
9. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783 [TBL] [Abstract][Full Text] [Related]
10. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine. Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411 [TBL] [Abstract][Full Text] [Related]
12. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886 [TBL] [Abstract][Full Text] [Related]
13. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease. Pashazadeh P; Marjani A; Asadi J; Khoshnia M Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123 [TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity. Reuther LO; Vainer B; Sonne J; Larsen NE Eur J Clin Pharmacol; 2004 Jan; 59(11):797-801. PubMed ID: 14634700 [TBL] [Abstract][Full Text] [Related]
15. Human thiopurine S-methyltransferase activity in uremia and after renal transplantation. Weyer N; Kröplin T; Fricke L; Iven H Eur J Clin Pharmacol; 2001 May; 57(2):129-36. PubMed ID: 11417444 [TBL] [Abstract][Full Text] [Related]
16. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population. Hindorf U; Peterson C; Almer S Ther Drug Monit; 2004 Dec; 26(6):673-8. PubMed ID: 15570193 [TBL] [Abstract][Full Text] [Related]
17. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans. Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718 [TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy. Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171 [TBL] [Abstract][Full Text] [Related]